| Name | small ubiquitin-like modifier 4 |
| Description | This gene is a member of the SUMO gene family. This family of genes encode small ubiquitin-related modifiers that are attached to proteins and control the target proteins' subcellular localization, stability, or activity. The protein described in this record is located in the cytoplasm and specifically modifies IKBA, leading to negative regulation of NF-kappa-B-dependent transcription of the IL12B gene. A specific polymorphism in this SUMO gene, which leads to the M55V substitution, has been associated with type I diabetes. The RefSeq contains this polymorphism. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSUMO4 is a member of the small ubiquitin‐like modifier protein family that exerts critical regulatory functions at the post‐translational level. It is well documented to conjugate to target proteins – most notably to IκBα – thereby repressing the transcriptional activity of nuclear factor κB (NF‐κB) and ultimately attenuating downstream pro‐inflammatory gene expression. A naturally occurring amino acid substitution (M55V) in an evolutionarily conserved region of SUMO4 has been shown to impair its inhibitory capacity, resulting in increased NF‐κB activity and elevated expression of cytokine genes, which is believed to contribute to the pathogenesis of autoimmune conditions such as type 1 diabetes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nUnder conditions of cellular stress, SUMO4 undergoes a rapid maturation process via stress‐induced hydrolases that expose its essential C‐terminal di‐glycine motif, a prerequisite for its conjugation to substrates. Once matured, SUMO4 can covalently attach to various target proteins—including key transcription factors besides IκBα—to fine‐tune the cellular response; for instance, its conjugation has been associated with repression of AP‐1 and AP‐2α transcriptional activity while enhancing glucocorticoid receptor DNA binding. In addition, evidence indicates that SUMO4 expression is controlled by NF‐κB itself, suggesting a negative feedback loop that restrains excessive inflammatory signaling."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "21"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nNumerous genetic association studies have linked SUMO4 polymorphisms—notably the M55V variant—to autoimmune and metabolic diseases including type 1 and type 2 diabetes, diabetic nephropathy, Graves’ disease, psoriasis, and other inflammatory disorders. Although many reports have focused on the allele frequency and clinical correlations in diverse ethnic populations (with some discrepancies between Asians and Caucasians), these studies underscore how alterations in SUMO4 function can modify immune responsiveness and stress regulation. Furthermore, investigations into other clinical contexts such as placental development, tacrolimus metabolism post–liver transplantation, and rheumatoid arthritis have also highlighted the broader relevance of SUMO4 activity in modulating disease phenotypes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "22", "end_ref": "28"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional studies have extended these observations to other immune‐mediated conditions, supporting the view that SUMO4 serves as a pivotal modulator of the immune response by controlling the amplitude and duration of critical signaling pathways under both basal and stress conditions. This convergence of mechanistic and clinical evidence reinforces the importance of SUMO4 sumoylation in maintaining immune homeostasis and mitigating aberrant inflammation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}, {"type": "fg_f", "ref": "5"}, {"type": "fg_f", "ref": "29"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Dehuang Guo, Manyu Li, Yan Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng1391"}], "href": "https://doi.org/10.1038/ng1391"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15247916"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15247916"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Claire E Jennings, Catherine J Owen, Valerie Wilson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "No association of the codon 55 methionine to valine polymorphism in the SUMO4 gene with Graves' disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Endocrinol (Oxf) (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2265.2005.02224.x"}], "href": "https://doi.org/10.1111/j.1365-2265.2005.02224.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15730420"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15730420"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "L J Gibbons, W Thomson, E Zeggini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Rheumatology (Oxford) (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/rheumatology/kei041"}], "href": "https://doi.org/10.1093/rheumatology/kei041"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16159953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16159953"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Masako Tsurumaru, Eiji Kawasaki, Hiroaki Ida, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus in the Japanese population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2006-0206"}], "href": "https://doi.org/10.1210/jc.2006-0206"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16735488"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16735488"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Gisela Orozco, Elena Sánchez, Miguel A González-Gay, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SLC22A4, RUNX1, and SUMO4 polymorphisms are not associated with rheumatoid arthritis: a case-control study in a Spanish population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Rheumatol (2006)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16821265"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16821265"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Shinsuke Noso, Hiroshi Ikegami, Tomomi Fujisawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of SUMO4, as a candidate gene for IDDM5, with susceptibility to type 1 diabetes in Asian populations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann N Y Acad Sci (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1196/annals.1375.006"}], "href": "https://doi.org/10.1196/annals.1375.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17130530"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17130530"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Hiroshi Ikegami, Tomomi Fujisawa, Yumiko Kawabata, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetics of type 1 diabetes: similarities and differences between Asian and Caucasian populations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann N Y Acad Sci (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1196/annals.1375.008"}], "href": "https://doi.org/10.1196/annals.1375.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17130532"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17130532"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Cong-Yi Wang, Robert Podolsky, Jin-Xiong She "}, {"type": "b", "children": [{"type": "t", "text": "Genetic and functional evidence supporting SUMO4 as a type 1 diabetes susceptibility gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann N Y Acad Sci (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1196/annals.1375.039"}], "href": "https://doi.org/10.1196/annals.1375.039"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17130563"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17130563"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Saikiran K Sedimbi, Arun Shastry, Yongsoo Park, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of SUMO4 M55V polymorphism with autoimmune diabetes in Latvian patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann N Y Acad Sci (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1196/annals.1375.041"}], "href": "https://doi.org/10.1196/annals.1375.041"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17130565"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17130565"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Hsing-Yi Lin, Chiao-Ling Wang, Pi-Jung Hsiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db06-1283"}], "href": "https://doi.org/10.2337/db06-1283"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17229939"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17229939"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "S K Sedimbi, A Kanungo, A Shastry, et al. "}, {"type": "b", "children": [{"type": "t", "text": "No association of SUMO4 M55V with autoimmune diabetes in Asian-Indian patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Immunogenet (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1744-313X.2007.00668.x"}], "href": "https://doi.org/10.1111/j.1744-313X.2007.00668.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17373940"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17373940"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Hiroshi Ikegami, Yumiko Kawabata, Shinsuke Noso, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetics of type 1 diabetes in Asian and Caucasian populations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes Res Clin Pract (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.diabres.2007.01.044"}], "href": "https://doi.org/10.1016/j.diabres.2007.01.044"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17452059"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17452059"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Kurt M Bohren, Kenneth H Gabbay, David Owerbach "}, {"type": "b", "children": [{"type": "t", "text": "Affinity chromatography of native SUMO proteins using His-tagged recombinant UBC9 bound to Co2+-charged talon resin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Protein Expr Purif (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.pep.2007.03.013"}], "href": "https://doi.org/10.1016/j.pep.2007.03.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17459725"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17459725"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "S K Sedimbi, X R Luo, C B Sanjeevi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Immun (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.gene.6364406"}], "href": "https://doi.org/10.1038/sj.gene.6364406"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17554341"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17554341"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Mariela Caputo, Gloria Edith Cerrone, C Mazza, et al. "}, {"type": "b", "children": [{"type": "t", "text": "No evidence of association of CTLA-4 -318 C/T, 159 C/T, 3' STR and SUMO4 163 AG polymorphism with autoimmune diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunol Invest (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/08820130601109735"}], "href": "https://doi.org/10.1080/08820130601109735"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17558709"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17558709"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Cong-Yi Wang, Jin-Xiong She "}, {"type": "b", "children": [{"type": "t", "text": "SUMO4 and its role in type 1 diabetes pathogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes Metab Res Rev (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/dmrr.797"}], "href": "https://doi.org/10.1002/dmrr.797"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17990297"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17990297"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Hong Li, Lin Gao, Zhu Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association study of NFKB1 and SUMO4 polymorphisms in Chinese patients with psoriasis vulgaris."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Dermatol Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00403-008-0843-4"}], "href": "https://doi.org/10.1007/s00403-008-0843-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18330586"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18330586"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Shengping Hou, Peizeng Yang, Liping Du, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SUMO4 gene polymorphisms in Chinese Han patients with Behcet's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Immunol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.clim.2008.06.006"}], "href": "https://doi.org/10.1016/j.clim.2008.06.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18657476"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18657476"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Wenzhong Wei, Ping Yang, Junfeng Pang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A stress-dependent SUMO4 sumoylation of its substrate proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2008.08.028"}], "href": "https://doi.org/10.1016/j.bbrc.2008.08.028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18708028"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18708028"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Shengping Hou, Peizeng Yang, Liping Du, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Vis (2008)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19122825"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19122825"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Cong-Yi Wang, Ping Yang, Manyu Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of a negative feedback network between SUMO4 expression and NFkappaB transcriptional activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2009.02.060"}], "href": "https://doi.org/10.1016/j.bbrc.2009.02.060"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19222990"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19222990"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Takeshi Shimada, Yasushi Furukawa, Hiroto Furuta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SUMO4 Met55Val polymorphism is associated with coronary heart disease in Japanese type 2 diabetes individuals."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes Res Clin Pract (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.diabres.2009.04.001"}], "href": "https://doi.org/10.1016/j.diabres.2009.04.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19410319"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19410319"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "R Podolsky, M V Prasad Linga-Reddy, J-X She "}, {"type": "b", "children": [{"type": "t", "text": "Analyses of multiple single-nucleotide polymorphisms in the SUMO4/IDDM5 region in affected sib-pair families with type I diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Immun (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/gene.2009.86"}], "href": "https://doi.org/10.1038/gene.2009.86"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19956095"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19956095"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Soudabeh Fallah, Mehrzad Jafarzadeh, Mehdi Hedayati "}, {"type": "b", "children": [{"type": "t", "text": "No association of the SUMO4 polymorphism M55V variant in type 2 diabetes in Iranian subjects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes Res Clin Pract (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.diabres.2010.05.033"}], "href": "https://doi.org/10.1016/j.diabres.2010.05.033"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20728233"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20728233"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Gwan Gyu Song, Sung Jae Choi, Jong Dae Ji, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between the SUMO4 M55V (A163G) polymorphism and susceptibility to type 1 diabetes: a meta-analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Immunol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humimm.2012.07.341"}], "href": "https://doi.org/10.1016/j.humimm.2012.07.341"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22884980"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22884980"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Dora Baczyk, Melanie C Audette, Sascha Drewlo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SUMO-4: A novel functional candidate in the human placental protein SUMOylation machinery."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0178056"}], "href": "https://doi.org/10.1371/journal.pone.0178056"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28545138"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28545138"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Tao Zhang, Yuan Liu, Yibo Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of donor and recipient SUMO4 rs237025 genetic variant with new-onset diabetes mellitus after liver transplantation in a Chinese population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2017.06.060"}], "href": "https://doi.org/10.1016/j.gene.2017.06.060"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28689037"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28689037"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Tao Zhang, Yuan Liu, Rong Zeng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of donor small ubiquitin-like modifier 4 rs237025 genetic variant with tacrolimus elimination in the early period after liver transplantation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Liver Int (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/liv.13597"}], "href": "https://doi.org/10.1111/liv.13597"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28941036"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28941036"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Yuejing Ding, Lei Cong, Iuliana Ionita-Laza, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Constructing gene association networks for rheumatoid arthritis using the backward genotype-trait association (BGTA) algorithm."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Proc (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1753-6561-1-s1-s13"}], "href": "https://doi.org/10.1186/1753-6561-1-s1-s13"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18466472"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18466472"}]}]}]}
|
| Synonyms | SUMO-4, SMT3H4, DJ281H8.4, IDDM5 |
| Proteins | SUMO4_HUMAN |
| NCBI Gene ID | 387082 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SUMO4 has 3,690 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 96 datasets.
Click the + buttons to view associations for SUMO4 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SUMO4 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SUMO4 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SUMO4 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SUMO4 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SUMO4 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SUMO4 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of SUMO4 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SUMO4 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SUMO4 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SUMO4 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SUMO4 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SUMO4 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with SUMO4 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of SUMO4 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SUMO4 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SUMO4 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SUMO4 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SUMO4 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SUMO4 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SUMO4 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SUMO4 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SUMO4 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for SUMO4 protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores | diseases involving SUMO4 gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving SUMO4 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with SUMO4 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SUMO4 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SUMO4 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SUMO4 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SUMO4 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SUMO4 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SUMO4 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SUMO4 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GAD Gene-Disease Associations | diseases associated with SUMO4 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with SUMO4 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of SUMO4 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SUMO4 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SUMO4 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SUMO4 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SUMO4 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SUMO4 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SUMO4 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SUMO4 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SUMO4 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SUMO4 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SUMO4 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SUMO4 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SUMO4 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing SUMO4 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing SUMO4 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by SUMO4 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by SUMO4 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SUMO4 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SUMO4 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SUMO4 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of SUMO4 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SUMO4 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with SUMO4 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with SUMO4 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SUMO4 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SUMO4 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SUMO4 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of SUMO4 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SUMO4 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPM Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of SUMO4 protein relative to other cell types and tissues from the HPM Cell Type and Tissue Protein Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for SUMO4 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with SUMO4 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SUMO4 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SUMO4 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SUMO4 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving SUMO4 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SUMO4 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SUMO4 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of SUMO4 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SUMO4 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing SUMO4 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SUMO4 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SUMO4 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MSigDB Cancer Gene Co-expression Modules | co-expressed genes for SUMO4 from the MSigDB Cancer Gene Co-expression Modules dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of SUMO4 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing SUMO4 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with SUMO4 gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SUMO4 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SUMO4 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SUMO4 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SUMO4 protein from the Wikipathways PFOCR 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SUMO4 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SUMO4 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of SUMO4 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SUMO4 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SUMO4 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SUMO4 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SUMO4 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SUMO4 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SUMO4 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SUMO4 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |